18F-氟胆碱数字PET/CT在甲状旁腺腺瘤检测中表现优于模拟系统
前瞻性纳入33例原发性甲状旁腺功能亢进且99mTc-MIBI显像阴性/不确定的患者,同次注射18F-氟胆碱后分别用数字与模拟PET/CT扫描。数字系统检出30/33例,模拟系统检出22/33例(p<0.01),数字系统对<10 mm病灶优势明显。
要点
- 数字PET/CT检出30/33例功能亢进甲状旁腺组织,模拟系统检出22/33例(p<0.01)。
- 仅数字系统检出的病灶均<10 mm(7.5±1.3 mm),两系统均检出者>10 mm(13±3.8 mm)。
- 甲状旁腺病灶SUVmax高于区域淋巴结(4.5±1.9 vs 2.9±1.3,p<0.0001)。
核心结论
- 数字PET/CT在疑似功能亢进甲状旁腺组织且既往影像阴性/不确定的患者中表现优于模拟系统,尤其对亚厘米病灶。
- SUVmax有助于区分功能亢进甲状旁腺组织与区域淋巴结。
研究设计与样本
- 前瞻性纳入33例原发性甲状旁腺功能亢进且99mTc-MIBI闪烁显像-SPECT/CT阴性/不确定的患者。
- 所有患者在同一次成像 session 中单次注射18F-氟胆碱后分别接受数字和模拟PET/CT扫描。
- 由3名核医学医师评估数字和模拟PET/CT数据集以评估功能亢进甲状旁腺组织的检出率。
主要发现
- 数字系统检出30/33例功能亢进甲状旁腺组织,模拟系统检出22/33例(p<0.01)。
- 在33例患者中,21例两系统均检出一个局灶性18F-氟胆碱摄取,1例数字系统检出两个病灶。
- 组织病理学证实32例为功能亢进甲状旁腺组织,1例不确定;数字PET/CT检出29/32例,模拟系统检出22/32例(p<0.01)。
- 仅由数字系统检出并切除的所有可疑功能亢进甲状旁腺病灶(n=8)均<10 mm(7.5±1.3 mm),两系统均检出的病灶(n=22)均>10 mm(13±3.8 mm)。
- 功能亢进甲状旁腺病灶的SUVmax显著高于区域淋巴结,与所用PET/CT系统无关(4.5±1.9 vs 2.9±1.3,p<0.0001)。
关键数值与推荐
- 数字系统检出率30/33 vs 模拟系统22/33(p<0.01)。
- 组织病理学证实病例中数字系统检出29/32 vs 模拟系统22/32(p<0.01)。
- 仅数字系统检出病灶大小7.5±1.3 mm(均<10 mm),两系统均检出病灶13±3.8 mm(均>10 mm)。
- 功能亢进甲状旁腺病灶SUVmax 4.5±1.9 vs 区域淋巴结2.9±1.3(p<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare detectability of hyperfunctioning parathyroid tissue (HPT) by digital and analog 18F-fluorocholine PET/CT in patients with primary hyperparathyroidism and negative/inconclusive 99mTc-MIBI scintigraphy-SPECT/CT. MATERIALS AND METHODS: Thirty-three patients with primary hyperparathyroidism and negative/inconclusive 99mTc-MIBI scintigraphy-SPECT/CT were prospectively included. All patients accepted to be scanned by digital and analog PET/CT in the same imaging session after a single injection of 18F-fluorocholine. Three nuclear medicine physicians evaluated the digital and analog PET/CT datasets to assess the detection rate of HPT. Maximum standard uptake values (SUVmax) of HPT and locoregional lymph nodes were measured in both systems. RESULTS: HPT was detected in 30/33 patients by the digital system, whereas it was detected in 22/33 patients by the analog system (p < 0.01). Moreover, in 21 of these 33 patients, both systems detected one focal 18F-fluorocholine uptake, and in one patient the digital system detected two foci. Histopathology demonstrated HPT in 32 patients and it was inconclusive in one patient. The digital PET/CT detected HPT in 29 of the 32 patients, and the analog system in 22 of the 32 (p < 0.01). All HPT suspected lesions resected and detected only by the digital system (n = 8) were < 10 mm (7.5 ± 1.3 mm), while those detected by both systems (n = 22) were > 10 mm (13 ± 3.8 mm). SUVmax of HPT lesions was significantly higher than SUVmax of locoregional lymph node independently of the PET/CT system used (4.5 ± 1.9 vs. 2.9 ± 1.3, p < 0.0001). CONCLUSIONS: Digital PET/CT offers superior performance over analog system in patients with suspected HPT and previous negative/inconclusive imaging examinations, particularly in sub-centimeter lesions. SUVmax can help in the differentiation between HTP and locoregional lymph nodes.
引用
- López-Mora DA, Sizova M, Estorch M, et al. Superior performance of 18F-fluorocholine digital PET/CT in the detection of parathyroid adenomas. Eur J Nucl Med Mol Imaging. 2020. PMID: 31919634. doi:10.1007/s00259-020-04680-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。